To assess the safety and efficacy of Flovent in children delivered by MDI and a spacer with a facemask. Have required maintenance asthma medication. Children 6 months to 23 months old. Children 24 months to 47 months old. Not be on any medications or have a medical condition which would exclude your participation.
Parents understand the study procedures and agree to participate by signing the informed consent.
Benefits of being in the study include free study medication, study related physician visits, lab work, and compensation for study time and travel. If you do not complete the study, you will be paid for only those visits completed. History of at least 6 months of asthma. Males 6,7, and 8 years old. Females 6 and 7 years old.